Register information Patent

DE file number : 60 2008 062 897.3 (Status: pending/in force, Query started: May 7, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2008 062 897.3
96EP file numberEAKZ16 16 7534.3
97EP publication numberEPN3078743
54Designation/titleTIGEGENMITTEL FÜR FAKTOR-XA-HEMMER UND VERFAHREN ZUR VERWENDUNG DAVON
51IPC main classICM
(ICMV)
C12N 9/64 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61P 7/04 (2006.01), A61K 38/48 (2006.01)
22DE application dateDATSep 26, 2008
96EP application dateEATSep 26, 2008
43Date of first publicationOTOct 12, 2016
Date of publication of grantPETJun 24, 2020
71/73Applicant/ownerINHAlexion Pharmaceuticals, Inc., Boston, MA, US
72InventorINLU, Genmin, Burlingame, CA 94010, US; PHILLIPS, David R., San Mateo, CA 94402, US; ANDRE, Patrick, Short Hills, NJ 07078, US; Sinha, Uma, San Francisco, CA 94127, US
Address for service RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
976343 P
Sep 28, 2007
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
90574 P
Aug 20, 2008
Due dateFT
FG
Sep 30, 2025
Annual fee for the 18th year Patent fees
Patent division in charge 44
21File number of protection certificateZAKZ12 2020 000 051.5
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003078743
Searchable text: EP000003078743
Original document: EP000003078743B1
Searchable text: EP000003078743B1
43Date of first publicationEVTOct 12, 2016
Date of the first transfer into DPMAregisterEREGTNov 25, 2016
Date of the (most recent) update in DPMAregisterREGTOct 2, 2024
(Show all update days)(Hide all update days)
  • Oct 2, 2024
    • Due date: changed
  • Oct 3, 2023; Oct 5, 2022; Oct 6, 2021; Jun 17, 2021; May 13, 2021; Apr 16, 2021; Jan 29, 2021; Dec 18, 2020; Oct 6, 2020; Aug 4, 2020; Jul 16, 2020; Jun 5, 2020; Jun 4, 2020; Aug 16, 2018; May 18, 2017
    • Historical data not available for this/these date(s)
  • Nov 25, 2016
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Oct 12, 2016  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Nov 24, 2016 Nov 24, 2016 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jun 24, 2020  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Jul 16, 2020 Jul 16, 2020 Details anzeigen
5 New applicant/owner details New applicant/owner details Dec 17, 2020 Jan 28, 2021 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Mar 25, 2021 Jun 17, 2021 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTOct 12, 2016
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTNov 24, 2016
Issue numberHN47
YearPJ2016
Publication dateVTNov 24, 2016
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJun 24, 2020
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJul 16, 2020
Issue numberHN29
YearPJ2020
Publication dateVTJul 16, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTJul 16, 2020
View procedures New applicant/owner details (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTDec 17, 2020
Issue numberHN4
YearPJ2021
Publication dateVTJan 28, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHAlexion Pharmaceuticals, Inc., Boston, MA, US
71/73Previous applicant/ownerINHFPortola Pharmaceuticals, Inc., South San Francisco, Calif., US
Date of update of the procedureREGTApr 16, 2021
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTMar 25, 2021
Issue numberHN24
YearPJ2021
Publication dateVTJun 17, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTJun 17, 2021